Your browser doesn't support javascript.
loading
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.
Pawlyn, C; Bright, M D; Buros, A F; Stein, C K; Walters, Z; Aronson, L I; Mirabella, F; Jones, J R; Kaiser, M F; Walker, B A; Jackson, G H; Clarke, P A; Bergsagel, P L; Workman, P; Chesi, M; Morgan, G J; Davies, F E.
Affiliation
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Bright MD; The Royal Marsden NHS Foundation Trust, London, UK.
  • Buros AF; The Institute of Cancer Research, London, UK.
  • Stein CK; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Walters Z; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Aronson LI; The Institute of Cancer Research, London, UK.
  • Mirabella F; The Institute of Cancer Research, London, UK.
  • Jones JR; The Institute of Cancer Research, London, UK.
  • Kaiser MF; The Institute of Cancer Research, London, UK.
  • Walker BA; The Royal Marsden NHS Foundation Trust, London, UK.
  • Jackson GH; The Institute of Cancer Research, London, UK.
  • Clarke PA; The Royal Marsden NHS Foundation Trust, London, UK.
  • Bergsagel PL; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Workman P; Department of Haematology, Newcastle University, Newcastle, UK.
  • Chesi M; The Institute of Cancer Research, London, UK.
  • Morgan GJ; Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Davies FE; The Institute of Cancer Research, London, UK.
Blood Cancer J ; 7(3): e549, 2017 03 31.
Article in En | MEDLINE | ID: mdl-28362441

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Cell Cycle Checkpoints / Enhancer of Zeste Homolog 2 Protein / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Cancer J Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Cell Cycle Checkpoints / Enhancer of Zeste Homolog 2 Protein / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Cancer J Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States